Dose ranging study and constant infusion evaluation of ciprofloxacin
- PMID: 3777907
- PMCID: PMC180576
- DOI: 10.1128/AAC.30.3.440
Dose ranging study and constant infusion evaluation of ciprofloxacin
Abstract
We evaluated the pharmacokinetics of 100- and 200-mg doses of ciprofloxacin, with the 200-mg dose administered either as a 30-min infusion or as a 100-mg loading dose followed by a 4-h constant infusion of 25 mg/h in six normal volunteers. No significant differences were seen in the dose-normalized area under the curve when the 100- and 200-mg 30-min administrations were compared. Differences that approached statistical significance were seen when data from either of these trials were compared with data from the constant-infusion arm. Serum clearances averaged 23.0 +/- 9.1 liters/h per 1.73 m2 for the 100-mg dose and 23.7 +/- 5.1 liters/h per 1.73 m2 for the 200-mg dose. Renal clearance accounted for approximately two-thirds of the serum clearance in each instance. Half-lives were slightly longer than 4 h. For the constant-infusion arm, serum clearance was 28.9 +/- 2.7 liters/h per 1.73 m2, with renal clearance accounting for 58% of serum clearance. Although no nonlinearities were apparent in the 100- to 200-mg dose range, larger doses, particularly in the multiple-dosing situation, may uncover nonlinearity in the disposition of ciprofloxacin.
Similar articles
-
Absolute oral bioavailability of ciprofloxacin.Antimicrob Agents Chemother. 1986 Sep;30(3):444-6. doi: 10.1128/AAC.30.3.444. Antimicrob Agents Chemother. 1986. PMID: 3777908 Free PMC article. Clinical Trial.
-
Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function.Antimicrob Agents Chemother. 1987 Jun;31(6):860-4. doi: 10.1128/AAC.31.6.860. Antimicrob Agents Chemother. 1987. PMID: 3619418 Free PMC article.
-
Multiple-dose pharmacokinetics of ciprofloxacin administered intravenously to normal volunteers.Antimicrob Agents Chemother. 1985 Aug;28(2):235-9. doi: 10.1128/AAC.28.2.235. Antimicrob Agents Chemother. 1985. PMID: 2939794 Free PMC article. Clinical Trial.
-
An overview of the pharmacology of intravenously administered ciprofloxacin.Am J Med. 1987 Apr 27;82(4A):339-45. Am J Med. 1987. PMID: 3578325
-
Penetration of ciprofloxacin into gynecologic tissues.Am J Med. 1987 Apr 27;82(4A):133-8. Am J Med. 1987. PMID: 3555027 Review.
Cited by
-
Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials.Clin Pharmacokinet. 2001;40(3):169-87. doi: 10.2165/00003088-200140030-00003. Clin Pharmacokinet. 2001. PMID: 11327197 Review.
-
A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life.Clin Pharmacokinet. 2018 Dec;57(12):1613-1634. doi: 10.1007/s40262-018-0661-6. Clin Pharmacokinet. 2018. PMID: 29737457 Free PMC article. Review.
-
Effect of dose on serum pharmacokinetics of intravenous ciprofloxacin with identification and characterization of extravascular compartments using noncompartmental and compartmental pharmacokinetic models.Antimicrob Agents Chemother. 1987 Nov;31(11):1782-6. doi: 10.1128/AAC.31.11.1782. Antimicrob Agents Chemother. 1987. PMID: 3435125 Free PMC article.
-
Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin.Antimicrob Agents Chemother. 1993 May;37(5):1065-72. doi: 10.1128/AAC.37.5.1065. Antimicrob Agents Chemother. 1993. PMID: 8517693 Free PMC article. Clinical Trial.
-
Pharmacokinetics of the newer fluoroquinolones.Pharm Weekbl Sci. 1987 Dec 11;9 Suppl:S16-22. doi: 10.1007/BF02075253. Pharm Weekbl Sci. 1987. PMID: 3325926 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources